DrugPatentWatch Database Preview
ZINGO Drug Profile
Email this page to a colleague
» See Plans and PricingWhen do Zingo patents expire, and what generic alternatives are available?
Zingo is a drug marketed by Powder Pharms and is included in one NDA. There are three patents protecting this drug.
This drug has sixteen patent family members in ten countries.
The generic ingredient in ZINGO is lidocaine hydrochloride. There are twenty-nine drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the lidocaine hydrochloride profile page.
US ANDA Litigation and Generic Entry Outlook for Zingo
A generic version of ZINGO was approved as lidocaine hydrochloride by WOCKHARDT BIO AG on November 18th, 1982.
Summary for ZINGO
| International Patents: | 16 |
| US Patents: | 3 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 2 |
| Bulk Api Vendors: | 5 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | ZINGO at DailyMed |
Pharmacology for ZINGO
| Drug Class | Amide Local Anesthetic Antiarrhythmic |
| Physiological Effect | Local Anesthesia |
US Patents and Regulatory Information for ZINGO
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Powder Pharms | ZINGO | lidocaine hydrochloride | SYSTEM;INTRADERMAL | 022114-001 | Aug 16, 2007 | RX | No | No | Start Trial | Start Trial | Start Trial | ||||
| Powder Pharms | ZINGO | lidocaine hydrochloride | SYSTEM;INTRADERMAL | 022114-001 | Aug 16, 2007 | RX | No | No | Start Trial | Start Trial | Start Trial | ||||
| Powder Pharms | ZINGO | lidocaine hydrochloride | SYSTEM;INTRADERMAL | 022114-001 | Aug 16, 2007 | RX | No | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ZINGO
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Powder Pharms | ZINGO | lidocaine hydrochloride | SYSTEM;INTRADERMAL | 022114-001 | Aug 16, 2007 | Start Trial | Start Trial |
| Powder Pharms | ZINGO | lidocaine hydrochloride | SYSTEM;INTRADERMAL | 022114-001 | Aug 16, 2007 | Start Trial | Start Trial |
| Powder Pharms | ZINGO | lidocaine hydrochloride | SYSTEM;INTRADERMAL | 022114-001 | Aug 16, 2007 | Start Trial | Start Trial |
| Powder Pharms | ZINGO | lidocaine hydrochloride | SYSTEM;INTRADERMAL | 022114-001 | Aug 16, 2007 | Start Trial | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ZINGO
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Austria | 329006 | Start Trial |
| United Kingdom | 9321356 | Start Trial |
| United Kingdom | 9326069 | Start Trial |
| India | 179833 | Start Trial |
| Bulgaria | 100047 | Start Trial |
| Hungary | T73516 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
